Something stinks in this country with Irish psychiatry and their cosy relationship with pharmaceutical companies. The two are seemingly (or unseemly) very closely involved and the small matter of “conflict of interests” doesn’t seem to enter into the equasion.
I found it very hard to understand why some members of Irish psychiatry seemed to have such a big issue with us telling the truth about the possible side effects of suicide/homicide associated with ssri antidepressants, and their frantic denials of either in the media. Surely public awareness can only be a good thing? It didn’t take much researching to find some members with very dubious cosy relationships with lundbeck and other pharmaceutical companies, mostly with their own particular brand of SSRI antidepressant…
Even our Ministers are in on the act; Pharmaceutical company Lundbeck’s Ireland offices, were officially opened by Mary Harney, TD, Minister for Health and Children. Health, children and Lundbeck Mary?
Seven of the eight professor’s who signed the letter in my previous post…
Prof Patricia Casey, UCD: Long history of collaboration with pharmaceutical company lundbeck, and has Previously sued Dr Michael Corry.
Prof Timothy Dinan, UCC: also a long history of collaboration with lundbeck and has lectured at meetings and served on advisory boards organised by companies promoting antipsychotic medications, including Eli Lilly, Janssen-Cilag, Pfizer and AstraZeneca, and is also a clinical trials subcommitee member with the Irish Medicines Board. He has lectured at meetings sponsored by or acted as an advisor to all companies who market a branded SSRI. He contributed to the Lundbeck Mental health barometer report. He has also previously made a complaint to the medical council against Dr Michael Corry.
Prof David Meagher, University of Limerick: Dr Meagher has received research grant funding from Astra-Zeneca and has acted as a advisory consultant for Pfizer, Eli-Lilly, Bristol-Meyers, and Janssen Pharmaceuticals as well as receiving travel support from Smith-Kline Beecham, Eli-Lilly, Astra-Zeneca, Novartis, Wyeth, and Bristol-Meyers Pharmaceuticals Ltd.
Prof Brian Lawlor, Saint James’s Hospital, Dublin: Prof Lawlor has loaned his name to and put his shoulder behind the ‘Mind Yourself — Mental Health in Later Life’ campaign, a project that has been enabled by the generous support of Lundbeck (Ireland) Ltd. He also contributed to the booklet of the same name.
Prof James v Lucey, St Patrick’s Hospital Dublin: Jan 07 Speaker at DIT Conference, sponsored by Lundbeck. Nov 2010 Lecture supported by educational grants from AstraZeneca, Janssen, Lundbeck and MPS. Speaker at the Royal College of Surgeons in Ireland (RCSI)’s Alumni Weekend 2011, sponsored by Fáilte Ireland; Global Medical; Hermitage Medical Clinic; Lundbeck; and Pfizer.
Prof Kevin Malone, St Vincent’s University Hospital/UCD: He is a co-founder of “Turn the Tide of Suicide” charity which was founded to raise awareness of the problem of suicide in Ireland and to raise funds to help lower suicide rates through dedicated research, educational support and intervention and yet will put his name to denials of side effects already admitted by pharmaceutical companies and disregard the findings of the only Irish expert on ssri antidepressants, Professor David Healy. Prof. Malone was a scientific advisor for the AFSP who’s founders were among others, Bristol Myers Squibb, Forest labs and J&j. Eli-Lilly was a benefactor and Lundbeck a listed patron.
Prof Michael Gill, TCD: was a judge at the All Ireland institute of psychiatry Belfast and was sponsored by GSK, makers of Seroxat. He is part of the VISIOn team which is sponsored by, among others, janssen-cilag, Astra zeneca, Pfizer and Eli-lilly. Professor Michael Gill and Dr Louise Gallagher of TCD’s Department of Psychiatry in the School of Medicine – will lead a €12 million Global Autism Genome Project, of which €5 million has been received from the Health Research Board (HRB), as well as an additional €7 million from a variety of international organisations.